Skip to main content

Next Generation: Biocompatible Microdevices

A new fabrication strategy enables scientists to manufacture fully biocompatible, implantable medical devices. 

Written byAbby Olena, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

An implantable wheel-like hydrogel Geneva drive uses a motorized magnet to move independently. A Geneva drive is an intricate mechanism used in the mechanical watchmaking industry that allows precise, consistent movement.SAU YIN CHINThe approach: Researchers have devised a technique to produce implantable microdevices made entirely of biocompatible hydrogels, according to a study published this week (January 4) in Science Robotics. And they used one such device to effectively target chemotherapy directly to bone tumors in a mouse model of osteosarcoma.

“Traditional implantable devices are made of silicon or metal, and there are certain manufacturing processes that you would use to make devices out of those materials,” coauthor Samuel Sia of Columbia University in New York City told The Scientist. “But they don’t work on biological materials which are much softer, and so we had to develop our own methods.”

Sia and colleagues generated and assembled several layers of nontoxic hydrogel polymers. By manipulating the length of the polymer chain, which changes the hydrogel’s mechanical and diffusive properties, the researchers were able to manufacture and assemble gears, gates, scaffolds, and posts into a variety of tiny machines. The addition of iron nanoparticles into parts of the devices meant the researchers could use a magnet outside of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo